0 items USD 0.00Search
Your search for "Breast%20Cancer%20Therapeutics" gave back 38673 results.
HER2, also known as human epidermal growth factor receptor 2, is an important prognostic factor for breast cancer.HER2 is also expressed on the...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Highlights The global CDK4 & 6 Inhibitors for Breast Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The breast cancer recurrence score test is a genomic test that extracts breast cancer tissue during surgery to check the activity of certain genes...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Market Analysis and Insights: Global CDK4 & 6 Inhibitors for Breast Cancer Market The global CDK4 & 6 Inhibitors for Breast Cancer market is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
HER2, also known as human epidermal growth factor receptor 2, is an important prognostic factor for breast cancer.HER2 is also expressed on the...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Breast Cancer Immunotherapy market size was valued at US$ 22120 million in 2022. With growing demand in downstream market and recovery...
Catalog:
LPI
August 2023
Price: USD 3,660.00
The “CDK4 & 6 Inhibitors for Breast Cancer Industry Forecast” looks at past sales and reviews total world CDK4 & 6 Inhibitors for Breast...
Catalog:
LPI
March 2023
Price: USD 3,660.00
HER2, also known as human epidermal growth factor receptor 2, is an important prognostic factor for breast cancer.HER2 is also expressed on the...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Breast Cancer Immunotherapy market size was valued at USD 23260 million in 2022 and is forecast to a readjusted size of USD 59490 million...
Catalog:
GIR
August 2023
Price: USD 3,480.00
Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Breast cancer is one of the most fatal cancer witnessed in women and is the second leading cause of death. It refers to cancer developed in breast...
Catalog:
Rockville Research
April 2019
Price: USD 1,100.00
Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Breast Cancer Monoclonal Antibodies market size was valued at US$ million in 2023. With growing demand in downstream market, the Breast...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer...
Catalog:
LPI
March 2023
Price: USD 3,660.00
